Concepedia

Fansheng Ran

FR

Statistics

Publications

10

Citations

194

H-Index

10

Active since

2015

Affiliations

Shandong University(Current)

The University of Texas MD Anderson Cancer Center

Nantong University

Fansheng Ran is an author at Shandong University specializing in pharmacology, drug discovery, and medicinal chemistry.

Publications per year

2015–2023

10

Publications

10

Discovery of novel pyrazole derivatives as potential anticancer agents in MCL

Fansheng Ran, Yang Liu, Daoguang Zhang et al. · Bioorganic & Medicinal Chemistry Letters · 2019 · 33 citations · Full text

, , +14

Design and synthesis of novel 1-substituted 3-(6-phenoxypyridin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine analogs as selective BTK inhibitors for the treatment of mantle cell lymphoma

Fansheng Ran, Yang Liu, Shengping Yu et al. · Bioorganic Chemistry · 2019 · 28 citations

, , +11

A Derivative of Piperlongumine and Ligustrazine as a Potential Thioredoxin Reductase Inhibitor in Drug-Resistant Hepatocellular Carcinoma

Jianqiang Qian, Zhongyuan Xu, Peng Zhu et al. · Journal of Natural Products · 2021 · 26 citations

, , +16

Discovery of pyrazolopyrimidine derivatives as potent BTK inhibitors with effective anticancer activity in MCL

Fansheng Ran, Yang Liu, Meixia Liu et al. · Bioorganic Chemistry · 2019 · 23 citations

, , +13

TME-targeting theranostic agent uses NIR tracking for tumor diagnosis and surgical resection and acts as chemotherapeutic showing enhanced efficiency and minimal toxicity

Zhongyuan Xu, Jianqiang Qian, Chi Meng et al. · Theranostics · 2022 · 20 citations · Full text

, , +17

1–5 of 10